Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学endocrine oncology

Ana O. Hoff

安娜·奥·霍夫

MD, PhD

🏢Instituto do Câncer do Estado de São Paulo (ICESP), University of São Paulo(圣保罗大学圣保罗州癌症研究所)🌐Brazil

Associate Professor; Head, Endocrine Oncology Section副教授;内分泌肿瘤科主任

42
h-index
2
Key Papers
3
Awards
3
Key Contributions

👥Biography 个人简介

Ana O. Hoff, MD, PhD is a leading endocrine oncologist at ICESP, University of São Paulo, recognized for her research on medullary thyroid cancer genetics, MEN2 kindreds in Brazilian populations, and hereditary endocrine tumor syndromes. She has characterized regional RET mutation spectra in Latin America, discovering novel pathogenic variants and adapting international surveillance guidelines to local genetic epidemiology. Her clinical program integrates molecular genetic testing with risk-stratified prophylactic interventions and has trained a generation of endocrine oncologists in Brazil and across Latin America.

Share:

🧪Research Fields 研究领域

Medullary Thyroid Cancer甲状腺髓样癌
RET MutationsRET基因突变
Adrenal Tumors肾上腺肿瘤
Hereditary Endocrine Neoplasia遗传性内分泌肿瘤
MEN2多发性内分泌腺瘤2型

🎓Key Contributions 主要贡献

RET Mutation Landscape in Brazilian MEN2 Kindreds

Characterized the spectrum of RET germline mutations in the largest Brazilian MEN2 registry, identifying population-specific variants and adapting risk-stratification guidelines for Latin American patients.

Prophylactic Thyroidectomy Protocols for MEN2 Carriers

Developed institutional protocols for risk-stratified prophylactic thyroidectomy in pediatric and adult MEN2 mutation carriers, demonstrating excellent long-term outcomes and contributing to Brazilian national guidelines.

Calcitonin Kinetics as Prognostic Biomarker in MTC

Defined calcitonin doubling time thresholds and their prognostic significance in MTC surveillance, providing practical tools for post-treatment monitoring and early detection of disease progression.

Representative Works 代表性著作

[1]

RET Proto-oncogene Mutations and Clinical Features of MEN2 in Brazil

Clinical Endocrinology (2018)

Comprehensive genetic epidemiology study defining RET mutation distribution in a large Brazilian MEN2 cohort and reporting genotype-phenotype correlations.

[2]

Calcitonin Doubling Time as a Prognostic Tool in Medullary Thyroid Carcinoma

Journal of Clinical Endocrinology & Metabolism (2021)

Validated calcitonin doubling time as an independent predictor of disease-specific survival in MTC patients after initial surgery.

🏆Awards & Recognition 奖项与荣誉

🏆Brazilian Society of Endocrinology Luís Décourt Research Award 2019
🏆Latin American Thyroid Society Distinguished Investigator Award 2022
🏆São Paulo Research Foundation (FAPESP) Thematic Project Grant 2020

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 安娜·奥·霍夫 的研究动态

Follow Ana O. Hoff's research updates

留下邮箱,当我们发布与 Ana O. Hoff(Instituto do Câncer do Estado de São Paulo (ICESP), University of São Paulo)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment